| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Laboratoriumsmedizin, Krankenhaus Nordwest, Steinbacher Hohl 2-26, 60488 Frankfurt/Main, Germany.
aAuthor for correspondence. Fax 49-69787390; e-mail TH-books{at}t-online.de.
Background: The hypochromic red cell is a direct indicator of functional iron deficiency (ID) in contrast to the majority of biochemical markers, which measure functional ID indirectly via iron-deficient erythropoiesis. The aim of this study was to evaluate the extent to which these biochemical markers can distinguish ID from anemia of chronic disease (ACD) as well as from the combined state of functional ID/ACD, using red cell hemoglobinization as the gold standard.
Methods: We studied 442 patients with various disease-specific anemias and 154 nonanemic patients. As indicators of red cell hemoglobinization, we measured the reticulocyte hemoglobin content (CHr) and the proportion of hypochromic red cells (HYPO), using an Advia 120 hematology analyzer. Ferritin, transferrin, transferrin saturation, and the concentration of the soluble transferrin receptor (sTfR) were determined by ELISA and immunoturbidimetric assay. The sTfR/log ferritin ratio (sTfR-F index) was used as an additional marker for biochemical identification of iron-deficient erythropoiesis.
Results: In a control group (n = 71), the 2.5 percentile values were 28 pg for CHr and 5% for HYPO. These values were used to indicate unimpaired red cell hemoglobinization and absence of functional ID. In patients with deficient red cell hemoglobinization but no acute-phase response (APR), iron-deficient erythropoiesis was indicated by serum ferritin and sTfR-F index values 
20.8 µg/L and >1.5, respectively. Corresponding values in patients with APR were 61.7 µg/L and >0.8, respectively. The positive likelihood ratios for the biochemical markers and the sTfR-F index for identifying iron-restricted erythropoiesis in patients with and without APR were 2.6–6.9 and 4.3–16.5, respectively.
Conclusion: In APR patients, biochemical markers demonstrate weaknesses in the diagnosis of functional ID as defined by hematologic indices. Use of diagnostic plots to illustrate the relationship between the sTfR-F index and CHr allows the progression of ID to be identified, regardless of whether an APR is present.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  H. T. Steinmetz, A. G. Tsamaloukas, S. Schmitz, J. Wiegand, R. Rohrberg, J. Eggert, H. Eustermann, H.-W. Tessen, and L. Thomas Analysis of Hypochromic Reticulocytes and Ferritin Index as a Rationale for An Effective Therapy of Cancer- and Chemotherapy-Associated Anemia Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 4578 - 4578. [Abstract]
|
|
|
|
 |
|
 P. van der Meer, D. J. Lok, J. L. Januzzi, P. W. B.-A. de la Porte, E. Lipsic, J. van Wijngaarden, A. A. Voors, W. H. van Gilst, and D. J. van Veldhuisen Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients Eur. Heart J., June 2, 2008; 29(12): 1510 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H.J.M. Kemna, H. Tjalsma, H. L. Willems, and D. W. Swinkels Hepcidin: from discovery to differential diagnosis Haematologica, January 1, 2008; 93(1): 90 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kupka, G. I. Msamanga, F. Mugusi, P. Petraro, D. J. Hunter, and W. W. Fawzi Iron Status Is an Important Cause of Anemia in HIV-Infected Tanzanian Women but Is Not Related to Accelerated HIV Disease Progression J. Nutr., October 1, 2007; 137(10): 2317 - 2323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Henry, N. V. Dahl, M. Auerbach, S. Tchekmedyian, and L. R. Laufman Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy Oncologist, February 1, 2007; 12(2): 231 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L Beard, L. E Murray-Kolb, F. J Rosales, N. W Solomons, and M. L. Angelilli Interpretation of serum ferritin concentrations as indicators of total-body iron stores in survey populations: the role of biomarkers for the acute phase response Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1498 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Crowell, A. M. Ferris, R. J. Wood, P. Joyce, and H. Slivka Comparative Effectiveness of Zinc Protoporphyrin and Hemoglobin Concentrations in Identifying Iron Deficiency in a Group of Low-Income, Preschool-Aged Children: Practical Implications of Recent Illness Pediatrics, July 1, 2006; 118(1): 224 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Opasich, M. Cazzola, L. Scelsi, S. De Feo, E. Bosimini, R. Lagioia, O. Febo, R. Ferrari, A. Fucili, R. Moratti, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure Eur. Heart J., November 1, 2005; 26(21): 2232 - 2237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ullrich, A. Wu, C. Armsby, S. Rieber, S. Wingerter, C. Brugnara, D. Shapiro, and H. Bernstein Screening Healthy Infants for Iron Deficiency Using Reticulocyte Hemoglobin Content JAMA, August 24, 2005; 294(8): 924 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Franck, J. Linssen, M. Messinger, and L. Thomas Potential Utility of Ret-Y in the Diagnosis of Iron-Restricted Erythropoiesis Clin. Chem., July 1, 2004; 50(7): 1240 - 1242. [Full Text] [PDF]
|
|
|
|
|
|
C. Brugnara Iron Deficiency and Erythropoiesis: New Diagnostic Approaches Clin. Chem., October 1, 2003; 49(10): 1573 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Choi and S. H. Pai Associations Between Serum Transferrin Receptor Concentrations and Erythropoietic Activities According to Body Iron Status Ann. Clin. Lab. Sci., July 1, 2003; 33(3): 279 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Beutler, A. V. Hoffbrand, and J. D. Cook Iron Deficiency and Overload Hematology, January 1, 2003; 2003(1): 40 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brugnara A Hematologic "Gold Standard" for Iron-deficient States? Clin. Chem., July 1, 2002; 48(7): 981 - 982. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
